Ethan Smith, Nuvolo’s VP and Head of Strategy & Operations, shares how biopharma organizations can better manage high-value assets by shifting away from outdated, frequency-based maintenance contracts. He highlights how relying on scheduled servicing—regardless of actual equipment usage—often leads to unnecessary costs, underutilization, and longer downtimes, especially when maintenance and calibration are handled by different vendors.
He explains how Nuvolo’s GxP asset management solution helps solve these problems with real-time utilization tracking and analytics. You’ll learn how this enables smarter maintenance planning, reduces unplanned downtime, and helps avoid duplicate equipment purchases. It’s a practical look at how life sciences companies can stay compliant, productive, and make better decisions with the right data in hand.